These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1285300)

  • 1. Development of inhibitors of reverse transcriptase and protease as therapeutics against HIV infection.
    Mitsuya H
    J Enzyme Inhib; 1992; 6(1):1-8. PubMed ID: 1285300
    [No Abstract]   [Full Text] [Related]  

  • 2. New wave antiretrovirals.
    Smart T
    GMHC Treat Issues; 1996 Sep; 10(9):1-3. PubMed ID: 11363838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic therapy for human immunodeficiency virus infection: a review.
    Neuzil KM
    Am J Med Sci; 1994 May; 307(5):368-73. PubMed ID: 7513499
    [No Abstract]   [Full Text] [Related]  

  • 4. Rationale and experience with reverse transcriptase inhibitors and protease inhibitors.
    Vella S
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S58-61. PubMed ID: 8595511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial: the development of novel inhibitors for the treatment of HIV infection.
    Tan JJ; Wang CX
    Curr Pharm Des; 2013; 19(10):1765-6. PubMed ID: 23092285
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination therapy in primary HIV infection.
    Perrin L; Hirschel B
    Antiviral Res; 1996 Jan; 29(1):87-9. PubMed ID: 8721554
    [No Abstract]   [Full Text] [Related]  

  • 7. Are we winning the battle against the human immunodeficiency virus.
    Sullivan AK; Nelson MR
    Br J Hosp Med; 1997 Nov 19-Dec 9; 58(10):486-8. PubMed ID: 10193449
    [No Abstract]   [Full Text] [Related]  

  • 8. Rational drug design and HIV: hopes and limitations.
    Goody RS
    Nat Med; 1995 Jun; 1(6):519-20. PubMed ID: 7585113
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiretroviral therapy and medical management of pediatric HIV infection and 1997 USPHS/IDSA report on the prevention of opportunistic infections in persons infected with human immunodeficiency virus.
    Pediatrics; 1998 Oct; 102(4 Pt 2):999-1085. PubMed ID: 9826994
    [No Abstract]   [Full Text] [Related]  

  • 10. How viral load's role measures up.
    Check W
    CAP Today; 1997 Dec; 11(12):1, 14-5, 18. PubMed ID: 10175995
    [No Abstract]   [Full Text] [Related]  

  • 11. Report from the 12th Retrovirus Conference. Hepatitis.
    Albrecht H
    AIDS Clin Care; 2005 Apr; 17(4):38-9. PubMed ID: 15875313
    [No Abstract]   [Full Text] [Related]  

  • 12. [The 39th ICAAC (San Francisco) and the 7th European Conference on Clinical Aspects and Treatment of HIV-infection (Lisbon). HIV infection: antiretroviral agents in the development and trial stage].
    Duval X
    Presse Med; 2000 Feb; 29(5):253-6. PubMed ID: 10701407
    [No Abstract]   [Full Text] [Related]  

  • 13. [New treatments for HIV].
    Garcia E
    Sidahora; 1996; ():48-50. PubMed ID: 11363630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing the new combination treatments.
    Hogan C
    GMHC Treat Issues; 1996 Aug; 10(8):11-2. PubMed ID: 11363718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicentric Castleman's disease in 2 patients with HIV infection, unresponsive to antiviral therapy.
    Bottieau E; Colebunders R; Schroyens W; Van Droogenbroeck J; De Droogh E; Depraetere K; De Raeve H; Van Marck E
    Acta Clin Belg; 2000; 55(2):97-101. PubMed ID: 10881375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guide to major clinical trials of antiretroviral therapy in human immunodeficiency virus-infected patients: protease inhibitors, non-nucleoside reverse transcriptase inhibitors, and nucleotide reverse transcriptase inhibitors.
    Tavel JA; Miller KD; Masur H
    Clin Infect Dis; 1999 Mar; 28(3):643-76. PubMed ID: 10194094
    [No Abstract]   [Full Text] [Related]  

  • 17. Interruption of reverse transcriptase inhibitors or a switch from reverse transcriptase to protease inhibitors resulted in a fast reappearance of virus strains with a reverse transcriptase inhibitor-sensitive genotype.
    Verhofstede C; Wanzeele FV; Van Der Gucht B; De Cabooter N; Plum J
    AIDS; 1999 Dec; 13(18):2541-6. PubMed ID: 10630523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher antiviral activity of antiretroviral regimens including protease inhibitors.
    de Mendoza C; Soriano V; Rodríguez-Rosado R; González-Lahoz J
    AIDS; 1999 May; 13(8):998-9. PubMed ID: 10371186
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiviral update.
    PI Perspect; 1996 Nov; (No 20):8-9. PubMed ID: 11363972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flying by the seat of our pants.
    Gilden D
    GMHC Treat Issues; 1996; 10(6/7):1-3. PubMed ID: 11363635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.